Please login to read the full article.
Scrip Regulatory Affairs
Impact assessment for recast of EU device directives over; centralised agency outcomes narrow
20 September 2011
Amanda Maxwell
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU parliament resolution plan expected to call for device pre-market authorisation system
- "Recast" of EU medtech directives becomes a "revision" as shape of change becomes clearer
- European Commission may allow SUD reprocessing but restrict movement of products
- Scope of EU device directives to be widened to include cosmetic devices & genetic tests
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
